Transcatheter Arterial Chemoembolization: Current Technique and Future Promise

Techniques in Vascular and Interventional Radiology

Volumn 10, Issue 1, 2007, Pages 2-11

  Liapi, Eleni ^a   Georgiades, Christos C ^a   Hong, Kelvin ^a   Geschwind, Jean Francois H ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

liver cancer; technique; transcatheter arterial chemoembolization

Indexed keywords

ANTIBIOTIC AGENT; CISPLATIN; DOXORUBICIN; IODINATED POPPYSEED OIL; MITOMYCIN C;

ARTICLE; CANCER THERAPY; CHEMOEMBOLIZATION; CONTINUOUS INFUSION; DEVICE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; TECHNIQUE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

ANGIOGRAPHY, DIGITAL SUBTRACTION; ANTINEOPLASTIC AGENTS; ARTERIES; CHEMOEMBOLIZATION, THERAPEUTIC; HUMANS; LIVER NEOPLASMS; RADIOGRAPHY, INTERVENTIONAL;

EID: 35548988344     PISSN: 10892516     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.tvir.2007.08.008     Document Type: Article

References (53)

1. Yamada R., Nakatsuka H., Nakamura K., et al. Hepatic artery embolization in 32 patients with unresectable hepatoma. Osaka City Med J 26 (1980) 81-96
2. Yamada R., Sato M., Kawabata M., et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148 (1983) 397-401
3. Geschwind J.F. Chemoembolization for hepatocellular carcinoma: Where does the truth lie?. J Vasc Interv Radiol 13 (2002) 991-994
4. Stuart K. Chemoembolization in the management of liver tumors. Oncologist 8 (2003) 425-437
5. Roche A., Girish B., de Baere T., et al. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 13 (2003) 136
6. Nakakuma K., Tashiro S., Hiraoka T., et al. Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer. Cancer 52 (1983) 2193-2200
7. Konno T., Maeda H., Iwai K., et al. Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: A preliminary report. Eur J Cancer Clin Oncol 19 (1983) 1053-1065
8. Clouse M.E., Perry L., Stuart K., et al. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Digestion 55 suppl 3 (1994) 92-97
9. Higuchi T., Kikuchi M., and Okazaki M. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases. Cancer 73 (1994) 2259-2267
10. Xiong Z.P., Yang S.R., Liang Z.Y., et al. Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 3 (2004) 386-390
11. Kobayashi N., Ishii M., Ueno Y., et al. Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization. Liver 19 (1999) 25-31
12. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332 (1995) 1256-1261
13. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
14. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet 359 (2002) 1734-1739
15. Aoki T., Imamura H., Hasegawa K., et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg 139 (2004) 766-774
16. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
17. Llovet J.M. Treatment of hepatocellular carcinoma. Curr Treat Options Gastroenterol 7 (2004) 431-441
18. Arii S., Yamaoka Y., Futagawa S., et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 32 (2000) 1224-1229
19. Livraghi T., Meloni F., Morabito A., et al. Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: Long-term survival in the experience of a single radiologic referral center. Liver Transpl 10 (2004) S98-S106
20. Burger I., Hong K., Schulick R., et al. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: Initial experience in a single institution. J Vasc Interv Radiol 16 (2005) 353-361
21. Chung J.W., Park J.H., Han J.K., et al. Hepatocellular carcinoma and portal vein invasion: Results of treatment with transcatheter oily chemoembolization. Am J Roentgenol 165 (1995) 315-321
22. Georgiades C.S., Hong K., D'Angelo M., et al. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 16 (2005) 1653-1659
23. Kamel I.R., Bluemke D.A., Ramsey D., et al. Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol 181 (2003) 708-710
24. Bruix J., Sala M., and Llovet J.M. Chemoembolization for hepatocellular carcinoma. Gastroenterology 127 (2004) S179-S188
25. Jaeger H.J., Mehring U.M., Castaneda F., et al. Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol 19 (1996) 388-396
26. Geschwind J.F., Ramsey D.E., van der Wal B.C., et al. Transcatheter arterial chemoembolization of liver tumors: Effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency. Cardiovasc Intervent Radiol 26 (2003) 111-117
27. Liapi E., Hong K., Georgiades C.S., et al. Three-dimensional rotational angiography: Introduction of an adjunctive tool for successful transarterial chemoembolization. J Vasc Interv Radiol 16 (2005) 1241-1245
28. Okuda K., Musha H., Yamasaki T., et al. Angiographic demonstration of intrahepatic arterio-portal anastomoses in hepatocellular carcinoma. Radiology 122 (1977) 53-58
29. Hong K., Liapi E., Georgiades C.S., et al. Case-controlled comparison of a percutaneous collagen arteriotomy closure device versus manual compression after liver chemoembolization. J Vasc Interv Radiol 16 (2005) 339-345
30. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
31. Tsuchida Y., and Therasse P. Response evaluation criteria in solid tumors (RECIST): New guidelines. Med Pediatr Oncol 37 (2001) 1-3
32. Murakami R., Yoshimatsu S., Yamashita Y., et al. Treatment of hepatocellular carcinoma: Value of percutaneous microwave coagulation. AJR Am J Roentgenol 164 (1995) 1159-1164
33. Castrucci M., Sironi S., De Cobelli F., et al. Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization. Abdom Imaging 21 (1996) 488-494
34. Bartolozzi C., Lencioni R., Caramella D., et al. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: Evaluation with contrast-enhanced MR imaging. AJR Am J Roentgenol 162 (1994) 827-831
35. Lim H.K., and Han J.K. Hepatocellular carcinoma: Evaluation of therapeutic response to interventional procedures. Abdom Imaging 27 (2002) 168-179
36. Takayasu K., Arii S., Matsuo N., et al. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol 175 (2000) 699-704
37. Bruix J., Llovet J.M., Castells A., et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution. Hepatology 27 (1998) 1578-1583
38. Livraghi T., Giorgio A., Marin G., et al. Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection. Radiology 197 (1995) 101-108
39. Simonetti R.G., Liberati A., Angiolini C., et al. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials. Ann Oncol 8 (1997) 117-136
40. Sullivan K.L. Hepatic artery chemoembolization. Semin Oncol 29 (2002) 145-151
41. Gupta S., Johnson M.M., Murthy R., et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors. Cancer 104 (2005) 1590-1602
42. Lang E.K., and Brown Jr. C.L. Colorectal metastases to the liver: Selective chemoembolization. Radiology 189 (1993) 417-422
43. Geschwind J.F., Salem R., Carr B.I., et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 127 (2004) S194-S205
44. Britten C., Finn R.S., Gomes A.S., et al. A pilot study of IV bevacizumab in hepatocellular carcinoma patients undergoing chemoembolization, 2005 ASCO Annual Meeting (2005) Orlando, Florida
45. Britten C. Chemoembolization and bevacizumab in treating patients with liver cancer that cannot be removed with surgery. National Cancer Institute (NCI) (2002). http://clinicaltrials.gov/show/NCT00049322 Record first received. November 12. Available at: http://clinicaltrials.gov/show/NCT00049322. Accessed October 3, 2007
46. Schwartz J.D. Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer (2003). http://ClinicalTrials.gov ClinicalTrials.gov. Record first received: March 6. Available at: http://www.clinicaltrials.gov/ct/show/NCT00055692. Accessed October 3, 2007
47. Foubister V. Energy blocker to treat liver cancer. Drug Discovery Today 7 (2002) 934
48. Park B.H., Lee J.H., Jeong J.S., et al. Vascular administration of adenoviral vector soaked in absorbable gelatin sponge particles (GSP) prolongs the transgene expression in hepatocytes. Cancer Gene Ther 12 (2005) 116-121
49. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364
50. Geschwind J.-F.H., Ramsey D.E., van der Wal B.C.H., et al. Transcatheter arterial chemoembolization of liver tumors: Effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency. Cardiovasc Intervent Radiol 26 (2003) 111
51. Geschwind J.F., Khwaja A., and Hong K. New intraarterial drug delivery system: Pharmacokinetics and tumor response in an animal model of liver cancer 2005 (2005) ASCO Annual Meeting. Orlando, Florida
52. Yoshizawa H., Nishino S., Shiomori K., et al. Surface morphology control of polylactide microspheres enclosing irinotecan hydrochloride. International J Pharm 296 (2005) 112-116
53. Horst J.J., Ulrich-Martin M., Francisco C., et al. Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol 19 (1996) 388